These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 29926707)

  • 1. Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome.
    Jeong YJ; Park SK; Yoon SJ; Park YJ; Lee MS
    J Microbiol Biotechnol; 2018 Sep; 28(9):1413-1425. PubMed ID: 29926707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).
    Exeni RA; Fernandez-Brando RJ; Santiago AP; Fiorentino GA; Exeni AM; Ramos MV; Palermo MS
    Pediatr Nephrol; 2018 Nov; 33(11):2057-2071. PubMed ID: 29372302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Shiga/Vero toxins in pathogenesis.
    Obata F; Obrig T
    Microbiol Spectr; 2014 Jun; 2(3):. PubMed ID: 25530918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monocytes stimulated by Shiga toxin 1a via globotriaosylceramide release proinflammatory molecules associated with hemolytic uremic syndrome.
    Brigotti M; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Valerii MC; Spisni E
    Int J Med Microbiol; 2018 Oct; 308(7):940-946. PubMed ID: 29983334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
    Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of the Shiga toxin in the hemolytic uremic syndrome].
    Creydt VP; Nuñez P; Boccoli J; Silberstein C; Zotta E; Goldstein J; Ibarra C
    Medicina (B Aires); 2006; 66 Suppl 3():11-5. PubMed ID: 17354471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network.
    Ardissino G; Vignati C; Masia C; Capone V; Colombo R; Tel F; Daprai L; Testa S; Dodaro A; Paglialonga F; Luini M; Brigotti M; Picicco D; Baldioli C; Pagani F; Ceruti R; Tommasi P; Possenti I; Cresseri D; Consonni D; Montini G; Arghittu M;
    J Pediatr; 2021 Oct; 237():34-40.e1. PubMed ID: 34197890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Therapeutic Developments against Shiga Toxin-Producing Escherichia coli.
    Melton-Celsa AR; O'Brien AD
    Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 26104346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2.
    Ibarra C; Amaral MM; Palermo MS
    IUBMB Life; 2013 Oct; 65(10):827-35. PubMed ID: 24014500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome.
    Karch H; Friedrich AW; Gerber A; Zimmerhackl LB; Schmidt MA; Bielaszewska M
    Semin Thromb Hemost; 2006 Mar; 32(2):105-12. PubMed ID: 16575685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Biology of
    Menge C
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32456125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.
    Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Fatal Role of Enterohaemorrhagic Escherichia coli Shiga Toxin-associated Extracellular Vesicles in Host Cells.
    Lee KS; Park JY; Jeong YJ; Lee MS
    J Microbiol; 2023 Aug; 61(8):715-727. PubMed ID: 37665555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.
    Detzner J; Pohlentz G; Müthing J
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32512916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Updates on Outbreaks of Shiga Toxin-Producing
    Kim JS; Lee MS; Kim JH
    Front Cell Infect Microbiol; 2020; 10():273. PubMed ID: 32582571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
    Müthing J; Schweppe CH; Karch H; Friedrich AW
    Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome.
    Petruzziello-Pellegrini TN; Moslemi-Naeini M; Marsden PA
    Virulence; 2013 Aug; 4(6):556-63. PubMed ID: 23955166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children.
    Brigotti M; He X; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Tazzari PL; Ricci F; Patfield SA; Testa S; Paglialonga F; Picicco D; Caprioli A; Scavia G; Morabito S; Ardissino G
    Thromb Haemost; 2020 Jan; 120(1):107-120. PubMed ID: 31858520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells.
    O'Loughlin EV; Robins-Browne RM
    Microbes Infect; 2001 May; 3(6):493-507. PubMed ID: 11377211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shiga/verocytotoxins and Shiga/verotoxigenic Escherichia coli in animals.
    Mainil J
    Vet Res; 1999; 30(2-3):235-57. PubMed ID: 10367357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.